Psyched: Top Psychedelics Execs., 50% Of Americans Support Medical Psychedelics, Cary Grant’s LSD Therapy & More
15 Global Psychedelics Executives To Keep An Eye On In 2022
Sirius XM Reports Q3 Subscriber Momentum; Boosts Dividend By 10%
Sirius XM Holdings Inc (NASDAQ:SIRI) reported third-quarter FY22 revenue growth of 4% year-on-year to $2.28 billion, beating the consensus of…
Zebra Technologies Shares Drop Following Q3 Miss; Warns On Near-Term Challenges
Zebra Technologies Corp (NASDAQ:ZBRA) reported a third-quarter FY22 net sales decline of 4% year-on-year to $1.38 billion, missing the consensus…
Pfizer’s Q3 Earnings Surpasses Estimates, Lifts Forecasts For COVID-19 Vaccine Sales By $2B
Pfizer Inc (NYSE:PFE) has reported a Q3 adjusted EPS of $1.78, up 40% Y/Y, well ahead of the consensus of…
LGI Homes Sees FY22 Home Closings Of 6,700 – 7,100 at ASP of $340K – $350K
Full Year 2022 Outlook
Subject to the caveats in the Forward-Looking Statements section of this press release, the Company is providing the following updates to its guidance for the full year 2022. The Company now
SiriusXM Reaffirms FY22 Guidance
2022 GUIDANCE
The company continues to expect positive full-year 2022 self-pay net subscriber additions and reiterated 2022 guidance for revenue, adjusted EBITDA, and free cash flow as follows:
Total
Eli Lilly Sees FY22 Adj EPS Of $7.70-$7.85 Vs. Prior Range Of $7.90-$8.05 And $8.08 Consensus
The company forecasts FY22 sales of $28.5 billion-$29.0 billion compared to previous guidance of $28.8-$29.3 billion and a consensus of $28.27 billion
Regal Rexnord Corp. Raising Guidance Mid-Point By Revising 2022 Annual Guidance For Adj. EPS To A Range Of $10.35-$10.75 From $10.20-$10.80 And Revising GAAP EPS Guidance To A Range Of $7.15-$7.55 From $7.01-$7.61
Raising Guidance Mid-Point By Revising 2022 Annual Guidance For Adjusted EPS To A Range Of $10.35 To $10.75 From $10.20 To $10.80 And Revising GAAP
Otter Tail Lowers FY22 EPS Guidance From $6.83-$7.13 To $6.42-$6.72 Vs $7.04 Est.
"We are adjusting our 2022 diluted earnings per share guidance to a range of $6.42 to $6.72 from our most recent guidance of $6.83 to $7.13 per share. This
Douglas Dynamics Sees FY22 Sales $600M-$630M Vs $608M Est., Adj. EPS $1.65-$2.05 Vs $1.81 Est., Adj. EBITDA $80M-$95M
Outlook
McCormick stated, "We are raising and narrowing our guidance ranges today given our robust performance so far this year, plus the positive demand trends we see and strong backlog in our Solutions